Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vera Therapeutics Inc Cl A
(NQ:
VERA
)
42.97
-4.37 (-9.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vera Therapeutics Inc Cl A
< Previous
1
2
3
4
5
6
7
Next >
Why Vera Therapeutics Stock Soared by 22% This Week
January 12, 2024
Executive changes and a bullish analyst take combined to boost sentiment on the company.
Via
The Motley Fool
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D. Turner as Chief Development Officer
January 08, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN on January 25, 2024
January 08, 2024
From
Vera Therapeutics
Via
GlobeNewswire
Recap: Vera Therapeutics Q3 Earnings
November 09, 2023
Via
Benzinga
Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy...
Via
Benzinga
Exposures
Product Safety
Vera Therapeutics' Kidney Disease Drug Has Opportunity In A Competitive Development Landscape: Analyst
December 18, 2023
Raymond James initiated coverage on Vera Therapeutics Inc (NASDAQ: VERA), a late-stage drug developer in the autoimmune kidney space. The lead asset, atacicept, is a BLyS/APRIL dual inhibitor fusion...
Via
Benzinga
This Promising Small-Cap Biotech Stock Could Rise 70%, According to Wall Street
December 15, 2023
Is the stock's risk worth the potential reward?
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 20, 2023
Via
Benzinga
Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
November 10, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results
November 09, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023
November 04, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics Scheduled to Present at November Investor Conferences
October 30, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics to Present Three Posters at the American Society of Nephrology Kidney Week 2023 Annual Meeting
October 13, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Why Shares of Vera Therapeutics Jumped Tuesday
September 26, 2023
The stock bounced back Tuesday from a three-month low it hit on Monday.
Via
The Motley Fool
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...
Via
Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Vera Therapeutics Scheduled to Present at September Investor Conferences
August 31, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
August 16, 2023
Via
Benzinga
Vera Therapeutics Provides Business Update and Reports Second Quarter Financial Results
August 10, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Around $8.5M Bet On Eagle Bulk Shipping? Check Out These 4 Stocks Insiders Are Buying
June 23, 2023
Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Why Shares of Vera Therapeutics Jumped Tuesday
June 20, 2023
The company announced early phase 2 trials information regarding its lead therapy.
Via
The Motley Fool
Vera Therapeutics Stock Is Trading Higher Today - Here's Why
June 20, 2023
On Saturday, Vera Therapeutics Inc (NASDAQ: VERA) announced that the Phase 2b ORIGIN trial of atacicept for the treatment of IgA nephropathy (IgAN) met its primary and key secondary endpoints, with...
Via
Benzinga
DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday
June 20, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
2 Surging Healthcare Stocks With More Fuel in the Tank
June 20, 2023
These stocks climbed 74% and 78% over the past month and there could be more gains ahead.
Via
The Motley Fool
Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress
June 17, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Vera Therapeutics to Host Presentation of Week 36 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN
June 15, 2023
From
Vera Therapeutics
Via
GlobeNewswire
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 15, 2023
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 14, 2023
Via
Benzinga
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 12, 2023
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.